France · Advertising framework
Influencer marketing for digital health products in France
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Medical-device claims must match the assessed purpose
Legal requirement — paraphrased
Applies when: The advertised product or software function is a medical device under the MDR.
For a regulated medical device, Article 7 prohibits misleading text, names and images, including unsupported functions, a false impression of treatment or diagnosis, omission of likely risks, and uses outside the purpose assessed for conformity. This includes software when it meets the medical-device definition.
Reimbursement and risk lists affect public device advertising
Legal requirement — paraphrased
Applies when: The offer is a medical device or accessory within CSP L5213; diagnostic IVDs require their own local provisions.
Public advertising of reimbursed devices and accessories is restricted, with a low-risk exception defined by the applicable list. Certain higher-risk devices require ANSM prior authorisation. Review the exact class, reimbursement status, current lists and device-specific requirements before choosing a public channel.
Channel rules
Check the complete consumer-facing message
Regulator guidance
The EU consumer-protection framework addresses misleading actions and omissions, including an overall deceptive presentation and undisclosed commercial intent. Review benefits, risks, qualifications and prices as a whole under the national implementing law. Space limits do not provide an automatic exemption from material information requirements.
Sources: EU Unfair Commercial Practices Directive 2005/29/EC
Review commercial identification and sector prohibitions
Regulator guidance
Commercial influencer content needs clear identification of its advertising nature. Health products and services also have specific restrictions, including prescription medicines and aesthetic medical procedures; a paid-partnership label does not make a prohibited endorsement lawful.
Review personal data separately from the advertisement
Legal requirement — paraphrased
Identify an Article 6 basis for personal-data processing and an applicable Article 9 condition for health data. Provide appropriate transparency and honour the right to object to direct marketing. Permission to deliver healthcare does not automatically authorise advertising use of patient data; electronic contact and trackers also need their own local review.
Brief the creator on the permitted message
Editorial recommendation
Check whether endorsements are permitted for the selected offer before contracting a creator. Record payments, gifts and affiliate links; specify the required advertising identification, approved claims, editing controls and takedown process.
Campaign workflow
Digital Health Products: prepare the review
Editorial recommendation
Classify each software function separately: lifestyle, medical software or delivery of care. Link accuracy and clinical outcome claims to the advertised software version and population. Review tracking and marketing data flows separately from permission to provide care.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Classify each software function separately: lifestyle, medical software or delivery of care.
- Link accuracy and clinical outcome claims to the advertised software version and population.
- Review tracking and marketing data flows separately from permission to provide care.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Dental communication, the March 2026 pharmacy code and device/IVD authorisation-list routes are now documented. Still verify the exact product classification, reimbursement, current ANSM decision and filing window, other professional codes and the actual influencer arrangement. The March 2026 visa form is evidence of that filing period, not confirmation of later filing dates.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
A digital-health offer promoted through influencer collaborations in France may combine a lifestyle function, medical software and a clinical service. Identify each advertised function and software version, then review clinical claims and the use of personal data separately.
Creator selection and commercial disclosure are only part of an influencer review. Examine the person's role, the spoken and visual claims, supplied benefits and the final publication together; a personal experience can still communicate a regulated claim.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. French health-product and professional communication baseline plus EU requirements. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- EU Medical Devices Regulation 2017/745
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Code de la santé publique: dispositifs médicaux
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU Unfair Commercial Practices Directive 2005/29/EC
EU framework implemented through national law; sector rules and local implementation also apply.
- Influenceurs: quels sont mes devoirs?
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- EU General Data Protection Regulation 2016/679
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
From framework to action
Local expertise in France
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in France.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.